SCHEMBL4923752

SCHEMBL4923752

Brc1cnc2nc(Br)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
DYRK1A Q13627 6/20 0.39
HTT P42858 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2A6 P11509 1/20 0.38
DYRK1B Q9Y463 6/20 0.36
AURKA O14965 2/20 0.36
CHEK1 O14757 1/20 0.36
DAPK3 O43293 1/20 0.36
JAK2 O60674 1/20 0.36
MAP4K4 O95819 1/20 0.36
PAK4 O96013 1/20 0.36
ABL1 P00519 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
IGF1R P08069 1/20 0.36
FGFR1 P11362 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30473687 0.79 BACE1 (0.50) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1
SCHEMBL4819657 0.79 BACE1 (0.50) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1
SCHEMBL31752133 0.79 SMN1; SMN2 (0.46) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1
SCHEMBL29862595 0.79 SMN1; SMN2 (0.38) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1
SCHEMBL12687394 0.79 DYRK1B (0.38) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1
SCHEMBL23360456 0.79 SMN1; SMN2 (0.38) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1
SCHEMBL21114788 0.79 NOS1 (0.37) SMN1; SMN2DYRK1AHTTMAPK1CYP2A6
SCHEMBL13226821 0.76 SMN1; SMN2 (0.40) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1
SCHEMBL1500697 0.76 SMN1; SMN2 (0.48) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1
SCHEMBL13208465 0.75 SMN1; SMN2 (0.41) SMN1; SMN2DYRK1AHTTNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080116789-A1 1, 5-NAPHTHYRIDINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080116789-A1 1, 5-NAPHTHYRIDINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE ARL1, NAP1L1, NAP1L4 SMN1; SMN2 4483/4885DYRK1A 3122/4885HTT 3024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.